PTC Therapeutics
PTCT
PTCT
65 hedge funds and large institutions have $600M invested in PTC Therapeutics in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
32
Reduced
11
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$63.6M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$23.6M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$23.3M |
| 4 |
O
OrbiMed
New York
|
+$21.7M |
| 5 |
PA
Perceptive Advisors
New York
|
+$17.6M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$12.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.79M |
| 3 |
DM
Deerfield Management
New York
|
-$5.95M |
| 4 |
Jennison Associates
New York
|
-$4.29M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$2.33M |
